Mission statement · Company scope
“Our mission is to afford early non-invasive detection of possible physical abnormalities including breast growths, testicular growths, blood flow and more.”
In use2026 – now1 sighting
First seenMay 2026Added
Last seenMay 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Product offering (primary)
- Leads with
- Product
- Best for
- Climate & health
- Formula
- We make [product] for [who]
- Tone
- Plain
- Length
- 21 words · reading grade 15
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.73
- Record
- st_b36921018f8b0a8a
- Classification confidence
- 0.50
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-05-06 · sec_sentence · 20-F/A · accession 0001683168-26-003530
View filing ↗0 to compareCompare